Overview
Neal Rothschild is an Oncologist in West Palm Beach, Florida. Dr. Rothschild is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Melanoma, Lung Cancer, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Egil And Pauline Braathen Center/Maroone Cancer Center
Nicolas Muruve is an Oncologist in Weston, Florida. Dr. Muruve is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Ureterocele, Muscle Invasive Bladder Cancer, Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.
Coral Springs Family Health And Surgery Center
Alberto Pieretti is an Oncologist in Parkland, Florida. Dr. Pieretti is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Thrombectomy.
Alan Koletsky is an Oncologist and a Hematologist in Delray Beach, Florida. Dr. Koletsky is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Non-Hodgkin Lymphoma, Familial Prostate Cancer, Urothelial Cancer, and Muscle Invasive Bladder Cancer. Dr. Koletsky is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Rothschild isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Lung CancerDr. Rothschild isDistinguished. Learn about Lung Cancer.
- MelanomaDr. Rothschild isDistinguished. Learn about Melanoma.
- Non-Hodgkin LymphomaDr. Rothschild isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Pleuropulmonary BlastomaDr. Rothschild isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- AgranulocytosisDr. Rothschild isAdvanced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Rothschild isAdvanced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Rothschild isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Rothschild isAdvanced. Learn about Chronic Familial Neutropenia.
- Desmoplastic Small Round Cell TumorDr. Rothschild isAdvanced. Learn about Desmoplastic Small Round Cell Tumor.
- Familial Colorectal CancerDr. Rothschild isAdvanced. Learn about Familial Colorectal Cancer.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Rothschild isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with MaturationDr. Rothschild isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Rothschild isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Rothschild isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Rothschild isExperienced. Learn about Acute Myelomonocytic Leukemia.
- ALK-Positive Non-Small Cell Lung CancerDr. Rothschild isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.